Orchid Chemicals' Betalactam API facility approved by MHRA, UK

Orchid Chemicals & Pharmaceuticals Ltd on January 22, 2007 has announced that its Betalactam Active Pharmaceutical Ingredient (API) facility located in Aurangabad, near Mumbai has been approved by the UK regulator, Medicines and Healthcare products Regulatory Agency (MHRA).

"This important regulatory approval received for this state-of-the-art manufacturing facility at Aurangabad is a major milestone for Orchid on several counts" observed Mr. K Raghavendra Rao, Managing Director, of the Company. The MHRA approval is an important step in the overall regulatory road map for and marketing of the Orchid's key betalactam product, Piperacillin - Tazobactam in the lucrative European markets. It also signifies the first major international approval for the Aurangabad API manufacturing complex which is slated to play a major role in diversification of the Orchid's product range in terms of niche, premium antibiotics and other pharmaceutical products, he said.

The Company would be formulating Piperacillin - Tazobactam in its state-of-the-art dosage form plant at Irungattukottai, Chennai which is also under the inspection processes. This product is part of the distribution arrangements with two reputed generic partners for the regulated markets of US and Europe.

Source : Equity Bulls

Keywords